Myriad Investor Day 2023 replay is now available. Watch now
Learn how genetic testing can provide better answers for the best prostate cancer treatment for you in our FREE Patient Testing Guide.
If you would like us to provide educational information about Prolaris to your healthcare provider, include their information below
Prostate cancer is personal, and your treatment should be too. The Prolaris genetic test provides personalized information about the aggressiveness of your prostate cancer, helping you to know if you are safe to forego treatment, if you should pursue treatment, and how much treatment is needed for the best possible outcome.
Testing with Prolaris is best done before making any prostate cancer treatment decisions. Any untreated patient diagnosed with localized prostate cancer is a candidate for Prolaris testing, including those who are:
Currently on active surveillance
Are you a metastatic prostate cancer patient?
The Prolaris test adds clinically-proven, objective information about your cancer’s behavior with traditional diagnostic tools like PSA and Gleason score. Prolaris test results have led to changes in prostate cancer management in up to 65% of patients.1-3
Prevents over or under treatment
Prolaris’s clinically validated thresholds reveal how aggressive your cancer is and how much treatment is needed. Knowing this information brings confidence to whatever decision you and your physician make about your treatment path.
Make educated decisions about treatment
Prolaris provides individualized information about your specific cancer to help you and your provider make informed and confident decisions on which treatment pathway is right for you. Prolaris can also help identify which men would benefit from adding hormone therapy (ADT) and who can safely avoid it.
Know your true cancer risk
Learn your risk of dying from prostate cancer in the next 10 years and understand your risk of cancer spreading outside of the prostate.
Prolaris results tell you if you’re safe to avoid treatment and actively keep watch, or if it makes sense to pursue surgery or radiation. Prolaris gives your doctor the information needed to create a personalized treatment plan. And it gives you a sense of relief that comes from knowing what to expect.
It starts with you! There’s no benefit in waiting for your doctor to suggest Prolaris, but there are big benefits to taking the test now. Be proactive and request our patient guide today. Download our tips and prepare for your upcoming appointment with accompanying materials to share with your doctor.
Doctor approves the test order
After the test is ordered, Myriad will obtain the necessary cancer tissue from an existing biopsy. No additional biopsies or blood draws are required.
Your genes are analyzed at our state-of-the-art facility
Myriad looks at your unique genetic information using the latest in sequencing.
Results are available in around 2 weeks
Once results are available, they are sent securely to your doctor’s office. Your doctor will help you understand the results.
Watch how Richard and his doctor worked together to decide on the best treatment option for him based on his Prolaris results.
A prostate cancer diagnosis can be devastating for you and your family, but it’s essential to remember that you have options. If you have questions about how to support your loved one during their prostate cancer journey, we can help.
Being a caregiver
Every Prolaris test provides actionable results to inform more confident prostate cancer treatment decisions.
Myriad is committed to providing patients with access to accurate and affordable genetic results through extensive coverage with most insurance plans and financial assistance programs.
Myriad believes in providing the most accurate and highest quality tests for patients. From hereditary cancer to precision medicine, our tests are designed to give providers and patients the most accurate answer possible.
Author: Geoff McLennan, prostate cancer patient and advocate Every January since 1951 the American Cancer Society (ACS) has published an annual report about...
Prostate cancer is a common cancer affecting men, and historically the most common approach to treatment would be either surgery or radiation therapy. However,...